EUNETWORKS
6.12.2022 09:46:41 CET | Business Wire | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that its Board of Directors has agreed to the appointment of Paula Cogan as its Chief Executive Officer, effective 1 January 2023. Paula currently holds the position of President, euNetworks. Paula will succeed CEO Brady Rafuse, who will become Chairman of euNetworks’ Board of Directors, with the existing Chairman Neil Hobbs remaining on the Board of Directors as a Non Executive Director.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221206005159/en/
Paula Cogan, euNetworks (Photo: Business Wire)
Paula is currently President, euNetworks, with responsibility for all operating aspects of the business. She joined euNetworks in November 2021, building on her 30 years of working in the telecoms industry. She has held various senior leadership positions in companies such as British Telecom, Verizon and Colt. Prior to joining euNetworks Paula was most recently Executive Vice President – Sales, Marketing and Customer Relationship Management at Colt, responsible for the commercial strategy of the business. Throughout her career Paula has been known for driving transformation in both teams and organisations, leading global sales, marketing, engineering and commercial teams as well as building successful channel strategies. With a strong track record in people management and mentoring, she is committed to promoting and driving inclusion and diversity within the telecoms Industry.
“I am excited to lead this exceptional and high-performing team of people through the next chapter of euNetworks’ growth,” said Paula Cogan. “euNetworks continues to distinguish itself in the digital infrastructure ecosystem, delivering critical internet infrastructure to customers. It’s an asset rich business, focused on developing and deepening its fibre networks, innovating and investing in new technologies to deliver highly scalable, owned and operated fibre-based and sustainable infrastructure in Europe. The vision that Brady and the team have followed and delivered creates an exciting opportunity for us all as we continue to drive the business forward. I want to thank Brady for that and also for his continued support as Chairman as we move forward in 2023.”
Brady joined euNetworks in March 2009. He has led euNetworks through its delisting on the Singapore Stock Exchange, privatisation with Columbia Capital, and sale to Stonepeak, with increased investment from IMCO. The business has become a critical bandwidth infrastructure company supporting Europe’s future bandwidth needs and a portfolio of customers who are the fastest growing consumers of bandwidth under his leadership. Brady has guided the company to become the leading data centre to data centre connectivity provider in Europe, with a unique set of connectivity options in both its metro and long haul network, including the development of Super Highways and new subsea cables. This has enabled the company to deliver exceptional growth and success, underpinned by a team with collective company values and a focus on the belief that bandwidth changes everything.
“I’m immensely proud of the team and it has been a privilege working with them as well as our investors, customers, partners and with the communities that we operate in across Europe,” said Brady Rafuse. “Paula is an exceptional leader. Her achievements in her career have been underpinned by her ability to foster strong relationships with customers and partners whilst remaining focused on leading organisations and people. Paula joined the euNetworks team a year ago and since then we have been working closely to ensure a smooth transition as we move forward with our plans and continue to grow the business. With Paula’s focus over the last year on all operating aspects of the business and her customer-centric approach, she has already made a great contribution to our performance in 2022 and I am excited for the company’s future with Paula as CEO. Thank you to Neil for his support, contribution and guidance since joining the euNetworks Board of Directors in January 2014. His extensive and global board and management experience has been hugely valuable to us all during his time as Chairman on our Board.”
“We know Paula is a fantastic leader and, like Brady, has a clear vision to guide euNetworks as we progress with growth plans for the business,” said Cyrus Gentry, Managing Director and Head of Communications, Europe at Stonepeak. “euNetworks is the fastest growing fibre business in Europe. It has a highly differentiated network platform that underpins the digital infrastructure ecosystem and there remains no shortage of compelling capital opportunities in Europe for euNetworks to further build on the unique position it has in the region. We extend our thanks to Brady for everything he has delivered as CEO, and we look forward to the value he will continue to deliver as Chairman.”
About euNetworks
euNetworks is a critical bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 490 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.
About Stonepeak
Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately $51.7 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, and to have a positive impact on the communities in which it operates. Stonepeak sponsors investment vehicles focused on private equity and credit. The firm provides capital, operational support, and committed partnership to sustainably grow investments in its target sectors, which include communications, energy transition, transport and logistics, and social infrastructure. Stonepeak is headquartered in New York with offices in Austin, Hong Kong, Houston, London and Sydney. For more information, please visit www.stonepeak.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005159/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom